Sign in or Sign up

User ID

Password

Remember me - forgot password

 

Sign up or Sign in

Name (in full)

Email address

Password

Confirm Password

 

Manufacturer(s) of Methylprednisolone in Pakistan.

BayerCirinHaji
MediceenaPearlPfizer

Methylprednisolone

Overview

Methylprednisolone is in a class of drugs called steroids. It is a corticosteroid and medrol drug.
Methylprednisolone Aceponate reduces swelling and inflammation. The actions, uses and adverse effects similar to prednisone.
Methylprednisolone (Na Succinate) is a chemically Methylprednisolone (Na Succinate) is 11ß, 17, 21-trihydroxy-6a-methylpregna-1, 4-diene-3, 20-dione 21- (sodium succinate). The actions, uses and adverse effects similar to prednisone. It reduces swelling and inflammation. Methylprednisolone (Na Succinate) is used to treat different disorders like allergic conditions, respiratory conditions, digestive problems, eye, skin, blood, rheumatic disorders etc.

Category:

Primary Characterstics

Methylprednisolone (Na Succinate), Methylprednisolone (Na Succinate) are the derivatives of Methylprednisolone. It is of Synthetic origin and belongs to Glucocorticoid. It belongs to Glucocorticoid agonist pharmacological group on the basis of mechanism of action and also classified in Dermatological Products and Corticosteroid Topical pharmacological group.The Molecular Weight of Methylprednisolone is 496.50.

Pharmacokinetics

Oral absorption of Methylprednisolone is found to be 95.5% ±4.5. Volume of distribution is found to be 1-1.5 l/kg and plasma protien binding is 77%. and metabolism is reported Hepatic. Renal Excretion accounts for 10%(IV)2-5%(other routes) and plasma half life is 1.1-3.1 hr.

Indications

Contraindications

Drug Interactions

Methylprednisolone is known to interact with other drugs, the details of drug interactions is as follows:

DrugDetailsSeverityOnsetManagement
Amphotericin BConcomitant use can lead to hypokalemia
AspirinMethyl prednisolone decreases the serum concentration and thus therapeutic effects of salicylates by increaseing renal clearence and inducing hepatic metabolism.ModerateMedications should be taken with food and immediately report the sign and symptoms of GI ulceration and bleeding.
Aspirin
CarbamazepineCarbamazepine accelerates metabolism of Corticosteroids (reduced effect).Major
Carbamazepine
Cyclophosphamide
Cyclosporin AConcomitant use can lead to convulsions
Cyclosporin A
ErythromycinErythromycin by interfering in hepatic and intestinal metabolism increases blood concentration of cyclosporine through CYP450 3A4 inhibition and may result in nephrotoxicity and neurotoxicity.ModerateGenerally avoid.Adjust dose and check cyclosporine blood levels and renal function.
Erythromycin
Estrogens Conjugated
GlibenclamideSteroids (e.g Methylprednisolone) induced hyperglycemia may partially antagonize the effect of hypoglycemic drugs (e.g Glibenclaimide)
LofexidineTheoretical potential for METHYLPREDNISOLONE reducing the HYPOTENSIVE effect of LOFEXIDINE HYDROCHLORIDE. Moderate
MetyrosineTheoretical potential for METHYLPREDNISOLONE reducing the HYPOTENSIVE effect of METIROSINE. Moderate
PhenobarbitoneBarbiturates (e.g. Phenobarbitone ) can increase metabolism of methyl prednisolone
Phenytoin (Na)
Pyridostigmine (Br)coadministration with corticosteroids such as methylprednisolone result in profound weaknessventilation
Rifampicin
Rotavirus vaccineThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence. Patients may be immunosuppressed if they have recently received Methylprednisolone.ModerateIn general, live virus or bacterial vaccines should not be used in patients receiving Methylprednisolone.
Tacrolimus

These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Interference in Pathology

  • Antigen Skin Test

Side Effects

The severe or irreversible adverse effects of Methylprednisolone, which give rise to further complications include Hypercalciuria, Congestive heart failure, Telangiectasia, Glaucoma, Cataract, Insomnia, Fluid retension, CHO intolerance, Peptic ulceration, Hypertension, Osteoporosis, Growth retardation, Aseptic bone necrosis, Viral infections, Hypokalemic alkalosis, Hemorrhages, Mood swings, Acute psychosis, Loss of matrix.

Methylprednisolone produces potentially life-threatening effects which include Cardiac arrhythmias, Hypotension, Cardiac Arrest, Bronchospasm, Anaphylactic reactions, Cardiovascular collapse. which are responsible for the discontinuation of Methylprednisolone therapy.

The signs and symptoms that are produced after the acute overdosage of Methylprednisolone include Hyperglycemia, Hyperuricemia.

The symptomatic adverse reactions produced by Methylprednisolone are more or less tolerable and if they become severe, they can be treated symptomatically, these include Erythema, Itching, Burning, Acneform, Folliculitis, Striae, Hypertrichosis/gingival hypertrophy, Fragility of skin, Menstrual irregularity, Facial erythema, Perioral dermatitis, Allergic skin reactions, Cushing syndrome, Hypopigmentation, Hyperpigmentation, Ecchymoses, Thin skin, Proximal myopathy, Skin atrophy, Vesiculation.

Available Brands

Click on the appropriate strength of the dosage form to view its available brands.

Single Ingredient

Inj: 1 g, 40 mg, 125 mg, 500 mg,
Oint: 0.1 %w/w,
Cream: 0.1 %w/w,

Dosage

Methylprednisolone's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

0.5 to 2 g1.2 (1.25)24 hourlyIV,IMFor 3 days
16 to 96 mg56 (56)24 hourlyPO4 divided doses with meal followed by 2 mg every 7 days
0.1 %0.1 (0.1)24 hourlyTopicalFor 12 weeks

Paedriatic Dosage ( 20 Kg. )

No data regarding the Paedriatic dosage details of Methylprednisolone is available.

Neonatal Dosage ( 3 Kg. )

No data regarding the neonatal dosage details of Methylprednisolone is available.

High Risk Groups

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Liver Malfunction, and Neonates.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Warning / Precautions

Do not have a vaccination, other immunization or any skin test while taking methylprednisolone unless doctor specifically recommended. Avoid use this drug during pregnancy or lactation. This can cause growth suppression in infants, so avoid use. It should be used with caution in patients with liver, kidney, intestinal or heart disease, hypothyroidism, high blood pressure, myasthenia gravis, osteoporosis (brittle bones), herpes eye infection or history of tuberculosis (TB), seizures, ulcers or blood clots. It should be used with caution if patient have a history of ulcers or take large doses of aspirin or other arthritis medication or use alcoholic beverages, because it may make stomach and intestines more susceptible to the irritating effects of alcohol, aspirin and certain arthritis medications, increasing risk of ulcers. Consult the doctor about any injuries or signs of infection (fever, sore throat, pain during urination and muscle aches) that occur during treatment and within 12 months after treatment with this drug, the dose may need to be adjusted or may need to start taking the drug again. It should be used with caution in patient with diabetes, because this drug may increase blood sugar level, test urine for sugar (glucose) frequently and contact the doctor if sugar is present, the dose of diabetes medication and diet may need to be changed.

Storage Conditions

Tab,Inj

Store Between 15°C-30°C. Do not Freeze. Protect from Sunlight and Moisture.

comments powered by Disqus